Time of Exercise Re-training With Chronic Obstructive Pulmonary Disease (COPD)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-85
SponsorMichaël RACODON

About this trial

Pulmonary rehabilitation (PR) is an effective intervention for reducing hospital readmissions, secondary events, and mortality in patients with respiratory pathologies.

The program should not be improved by introducing new subjects such as circadian rhythm.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age ≥ 18 years

Patient with chronic obstructive pulmonary disease (COPD)

Registered for respiratory re-education and rehabilitation at the Clinique de la Mitterie

Number of rehabilitation sessions at least 18 over 4 weeks

Disqualifiers

- cardiovascular contraindications to exercise

unstable respiratory status (uncompensated respiratory acidosis)

conditions interfering with the pulmonary rehabilitation process (progressive neuromuscular disease, psychiatric illness)

Trial design

Design model

Parallel

Treatments tested in this trial

  • Pulmonary rehabilitation

    Other intervention

    Pulmonary rehabilitation includes : * Exercise re-training with resumption of physical activities * therapeutic patient education

Treatment groups

90 Participants
are divided into 2 treatment groups
Group A: Morning groupOther 1 intervention
Group B: Afternoon groupOther 1 intervention

Trial outcomes

Primary outcomes

1

6-minute walk test (6MWT)

Walking distance in a test

Time frame
15 minutes

Secondary outcomes

1

Time limit test (Time-lim)

Endurance exercise holding time in seconds

Time frame
0 to 900 secondes
2

Sit to stand test (STT)

The number of sit-to-stand repetitions during the test.

Time frame
1 minute
3

Single arm curl Test (SAC)

The number of bends during the test

Time frame
1 minute
4

Single-leg stance test (SLT)

The time for balance

Time frame
1 minute

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Michaël RACODON

Lead sponsor

Clinique de la Mitterie

Sponsor institution